Skip to main content
IDEXX LABORATORIES INC /DE logo

IDEXX LABORATORIES INC /DE — Investor Relations & Filings

Ticker · IDXX ISIN · US45168D1046 LEI · OGMTXK0LUU1HKV2P0J84 US Professional, scientific and technical activities
Open in API
Filings indexed 1,395 across all filing types
Latest filing 2016-05-03 Director's Dealing
Country US United States of America
Listing US IDXX

About IDEXX LABORATORIES INC /DE

https://www.idexx.com/

IDEXX Laboratories, Inc. is a global leader in diagnostics and software for the veterinary, livestock, and water testing markets. The company develops, manufactures, and distributes a broad range of products and services aimed at enhancing the health and well-being of pets, people, and livestock. Core offerings include in-clinic point-of-care diagnostic instruments and tests, a global network of reference laboratories providing advanced testing services, and practice management software solutions for veterinarians. These integrated solutions provide veterinarians with actionable insights to deliver advanced medical care and improve practice efficiency.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2016-05-03 English
10-Q
Interim / Quarterly Report Q1 2016
2016-04-29 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 29, 2016, reporting the company's financial results for the quarter ended March 31, 2016. It includes a press release titled 'IDEXX Laboratories Announces First Quarter Results.' The document is relatively short (3367 characters) and primarily serves to announce the earnings results rather than providing detailed financial statements or comprehensive analysis. The presence of a press release announcing quarterly results aligns with the definition of an Earnings Release (ER).
2016-04-29 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2016-03-25 English
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
Remuneration Information Classification · 95% confidence The document is titled 'DEFA14A' which corresponds to Definitive Additional Proxy Soliciting Materials. It is a Schedule 14A filing under the Securities Exchange Act of 1934, specifically related to proxy statements and soliciting materials for the 2016 Annual Meeting of Stockholders of IDEXX Laboratories, Inc. The content includes information about the proxy materials availability, voting instructions, and proposals to be voted on at the meeting, such as election of directors, ratification of auditors, and advisory vote on executive compensation. This type of document is classified as Remuneration Information (DEF 14A) because it includes proxy solicitation materials with executive compensation proposals and related governance matters. It is not the proxy statement itself but additional definitive materials related to the proxy solicitation, which fits the DEF 14A category.
2016-03-24 English
FORM 4
Director's Dealing
2016-02-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.